Spero Therapeutics, Inc.
Spero Therapeutics, Inc. scores highest on Price (75) and lowest on Nitro (24). Its PosiPenta is 51.82 out of 100, around the middle of similar companies.
On the Penta Grid this week, Spero Therapeutics, Inc. is Grid #254 of 837 in the Healthcare sector in United States, and Grid #1,664 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | 51.82 | 75 | 39 | 24 | 74 | 47 |
| Verrica Pharmaceuticals Inc. | 30.34 | 5 | 34 | 31 | 33 | 49 |
| Tenax Therapeutics, Inc. | 37.13 | 46 | 31 | 8 | 65 | 34 |
| Oncolytics Biotech Inc. | 44.43 | 0 | 59 | 33 | 93 | 37 |
| Champions Oncology, Inc. | 44.85 | 4 | 83 | 40 | 35 | 62 |
| Fortress Biotech, Inc. | 57.23 | 93 | 46 | 27 | 69 | 50 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 7.86 |
| P/B ratio | 1.45 |
EEarnings
| Trailing EPS | ₹13.26 |
| Forward EPS | ₹-105.13 |
NNitro
| Price | 104.19 |
| 52-week high | 291.72 |
| 52-week low | 102.29 |
| Fall from 52-week high | 64.3% |
TTorque
| Return on equity (ROE) | 19.17% |
| Debt-to-equity | 0.05 |
AAnchor
| Beta (price swings) | 1.50 |
| Market cap | ₹606 Cr |
| Insider holding | 22.66% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Spero Therapeutics, Inc.'s PosiPenta score?
Spero Therapeutics, Inc.'s PosiPenta is 51.82 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Spero Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Spero Therapeutics, Inc. is Grid #254 of 837 in the Healthcare sector in United States, and Grid #1,664 of 4,000 in United States.
Which PosiPenta pillar is strongest for Spero Therapeutics, Inc.?
Price (valuation), with a score of 75 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Spero Therapeutics, Inc.?
Nitro (momentum), with a score of 24 out of 100: weaker than most similar companies.
Has Spero Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.63 points, from 50.19 to 51.82.
PositoAI is for research and education only and is not investment advice.